I was just wondering if you could clarify a few of your comments you made previously...
------------------- 31/1/2012
The FDA approval for Phase 3 has been granted as per the entry on the ClinicalTrials.gov website, date of entry January 29, 2012. Marty will make an announcement to the market to confirm this significant milestone for Prima. The market needs to wake up and realise that the approval means that phase 2b is a success otherwise we wouldn't be running with an FDA approved Phase 3 trial, Hello any one home. -------------------
31/1/2012
Westhx Are you for real posting this comment "I hope it's not (successful) because you own PRR again" You need help my friend. Mate I feel sorry for you that all your stocks are down but there is only one person to blame for that. Do you think the FDA said yeah keep the trial going you Aussie boys (based on jack s###) spend a few million and start enrolling another 1000 suckers we'll look at all the patient charts in a few months time and if there dropping off early compared to the statistical documented PFS we'll just call it all off then mate. Delusional Westhx!!!!!!!!
---------------- 1/2/2012
Westhx
I acknowledge my misinterpretation re you comment, 29 thumbs up woohoo :) how much money did you make from that :)
As for my post being labeled "rubbish" try and think a little outside the square mate. Do you really think the FDA would approve a Phase 3 Trial of this magnitude to commence without reviewing documentation on the progress of patients in the current Phase2b? Are you suggesting that when interim result are released/due in 6 months (so you say) if they are not up to scratch the phase 3 trial will be pulled, delusional Westhx.
Have you even come across any documentation that suggests an FDA Phase 3 trial was discontinued based on phase 2 results lol.
You say I'm pumping misleading information, have people lost money from my misleading information(my opinion) on this forum westhx? This is what you posted in April @36 cents, when I called the downtrend in this stock....talk about misleading....
""The stock is going up because of anticipation and news. The good news is that the anticipation will not subside this year. Therefore any correction should be treated as a buying opportunity.""
Westhx you label yourself a long term holder, here is the contents of three of your four last posts prior to yesterday.... brilliant fundamental analysis in my opinion real longterm vision here.....
"'It is working towards a capitulation point and I do intend a bounce trade once the volume picks up Traders will be all over this when the volume kicks in, some will hold most will not""
""Third crack at 18 cents rejected again. When it does break 18 a pressure valve will be released.""
""once 14 cents gets taken out below 10 cents cannot be discounted if markets continue to plunge and no news is forthcoming from PRR. It all technical trading in the absence of news.""
I hope your guesses on the longterm outcome OF PRR's shareprice are a lot more researched and accurate than your shortterm guesses. As always, all in my opinion,Goodluck with it. ------------------------ 2/2/2012
Another Cancer Vaccine showing promise........ask yourselves will this space reignite in 2012? .....Check news on Dendreon, Gold is out Johnson is in.....will this early promising trend in International markets continue in 2012?
The rule for traders is to always trade the chart, never the news. The news always follows the mood and the mood drives the markets. Mood always comes first and the trends grow out of the mood.
What mood have some of you guys been in lately on this thread, about time you changed :)
Call it ramping if you like, I call it research and sharing one's opinion, Goodluck with it.
"Vaccine to treat breast cancer 'promising' say experts
A pioneering vaccine to treat breast cancer using a patient's own cells has been developed by scientists.
The researchers say the results provide new evidence therapeutic breast cancer vaccines may be most effective for early, localised disease. By Rebecca Smith, Medical Editor
7:15AM GMT 01 Feb 2012
The vaccine was described as "promising" after 85 per cent of women with a ductal carcinoma in situ (DCIS) - the most common non-invasive form of the disease - were still showing protection after four years."
So just to clarify, you no longer believe that it is intuitive to think that Cvac is successful. In fact, you now believe that there is no chance that Cvac is successful.
And all this, based on pretty much the exact same information. the only thing to have changed was that PROMISING INTERIM PHASE IIb data was released. The same Phase IIb trial that the market was supposed to "wake-up to".
If you could, please let me know what EXACTLY caused your position/opinion on Cvac to change.
PRR Price at posting:
9.8¢ Sentiment: Hold Disclosure: Held
(20min delay)